BTC Health (ASX:BTC) EBITDA Margin %: 0.00% (As of Dec. 2025)


What is BTC Health EBITDA Margin %?

BTC Health ASX:BTC EBITDA Margin % is 0.00% as of Dec. 2025. The stock has 3 warning signs investors should review. Among 944 Biotechnology companies, BTC Health ranks worse than 105932.1% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. BTC Health's EBITDA for the six months ended in Dec. 2025 was A$-0.08 Mil. BTC Health's Revenue for the six months ended in Dec. 2025 was A$0.00 Mil. Therefore, BTC Health's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.

BTC Health  (ASX:BTC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

BTC Health EBITDA Margin % Related Terms

BTC Health EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for BTC Health's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BTC Health EBITDA Margin % Chart

BTC Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,061.54 -613.83 0.00 0.00 0.00

BTC Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ASX:BTC vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, BTC Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BTC Health EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BTC Health's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where BTC Health's EBITDA Margin % falls into.


BTC Health EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

BTC Health's EBITDA Margin % for the fiscal year that ended in Jun. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-0.675/0
= %

BTC Health's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.084/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
BTC Health (ASX:BTC) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on BTC Health and its competitors. According to the industry distribution chart, BTC Health ranks #999999 out of 944 companies in the Biotechnology industry.
Is BTC Health's EBITDA Margin % too high?
BTC Health's current EBITDA Margin % is 0.00%. Based on the distribution chart, BTC Health ranks #999999 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does BTC Health's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BTC Health ranks #999999 out of 944 companies for EBITDA Margin %. This places BTC Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on BTC Health and its competitors. BTC Health's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BTC Health stock overvalued right now?
BTC Health (ASX:BTC) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For BTC Health (ASX:BTC), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BTC Health Business Description

Address 10 Oxley Road, Level 1, Hawthorn, Melbourne, VIC, AUS, 3122
BTC Health Ltd is a pooled development fund focused on seeking new investment opportunities in entities operating in the biotechnology and life sciences sectors. Its sole operating segment involves making and managing healthcare ventures. The company's products include Elasto-Q, Rythmic Infusion Pumps, Tiva, Infusion and Nerve Catheter Kits, Biopsy Needles, Radiological Markers, Rebellion Bone Removal System, Bonopty Coaxial Bone Biopsy, ECLS (Extracorporeal Life Support) Oxygenators, Pears, Valves, NEOLA, and LPS Adsorber. Geographically, it operates in Australia.